FDA approves Wegovy to reduce heart disease and stroke risk
The FDA has approved Wegovy to reduce cardiovascular risk in people with obesity, based on results from Novo Nordisk’s SELECT trial. Excess weight raises the
The FDA has approved Wegovy to reduce cardiovascular risk in people with obesity, based on results from Novo Nordisk’s SELECT trial. Excess weight raises the
New research has found that – two years after the end of a randomized trial that showed a benefit of daily Vitamin D and Omega-3
Eli Lilly has announced that it would bring the Mounjaro drug against obesity and diabetes to British patients, weeks after winning clearance for pre-filling it
Researchers from Australia and Norway have developed a new form of insulin that can be taken by mouth rather than injection. The pills travel through
A commonly prescribed drug for rheumatoid arthritis could be used to slow the progress of Type 1 diabetes, new research shows.In the study, the immunotherapy
Several types of human insulin can be stored unopened at temperatures of 25 °C (77 °F) for up to six months and at 37 °C
Researchers have developed a self-adjusting nanoparticle-based insulin formulation that may go some way towards improving blood glucose control. A team of Chinese researchers has used
A new study has found health concerns about the sugar substitute sucralose so alarming that researchers have advised that people should stop eating it and
The French National Agency for Medicines and Health Products Safety (ANSM) has conditionally authorized AMX0035, a new medication developed by the American laboratory Amylyx Pharmaceuticals
A study of almost 100,000 eyes has found that semaglutide, a GLP-1 agonist recently approved for weight loss, does not worsen the progression of diabetic